| Suspended | Methadone as an Alternative Treatment for Children Underdoing HSCT NCT06940570 | University of Texas Southwestern Medical Center | Phase 3 |
| Not Yet Recruiting | Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leu NCT07439211 | Jacqueline Garcia, MD | Phase 1 |
| Recruiting | Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia NCT07405424 | University of Chicago | N/A |
| Recruiting | Pre-malignant States to Hematologic Malignancies in Firefighters NCT06870760 | Wake Forest University Health Sciences | — |
| Recruiting | Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host NCT07249346 | Hannah Choe, MD | Phase 2 |
| Enrolling By Invitation | Natural History Study of Early Life Exposures in Agriculture (ELEA) NCT07328516 | National Cancer Institute (NCI) | — |
| Not Yet Recruiting | Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers NCT07524530 | National Cancer Institute (NCI) | Phase 2 |
| Not Yet Recruiting | ALL Backbone in AYAs NCT07227584 | Dana-Farber Cancer Institute | Phase 2 |
| Not Yet Recruiting | Clonal Hematopoiesis of Immunological Significance NCT05969821 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | Weight Gain in Pediatric Leukemia Survivors NCT07374315 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors NCT07483749 | The Children's Hospital of Zhejiang University School of Medicine | — |
| Recruiting | CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL NCT07294677 | University of Chicago | Phase 1 / Phase 2 |
| Recruiting | Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies NCT05544968 | Medical College of Wisconsin | Phase 1 |
| Recruiting | Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients U NCT06856226 | National Cancer Institute (NCI) | — |
| Not Yet Recruiting | Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study NCT07292272 | University of Nebraska | Phase 2 |
| Recruiting | Cohort of Patients With Chronic Myelomonocytic Leukemia NCT07512882 | Gustave Roussy, Cancer Campus, Grand Paris | — |
| Recruiting | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid NCT07148180 | Jacqueline Garcia, MD | Phase 1 / Phase 2 |
| Recruiting | A Study of Revumenib and Mezigdomide in People With Leukemia NCT07356154 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellul NCT07051525 | Peter MacCallum Cancer Centre, Australia | N/A |
| Recruiting | Mosunetuzumab for CLL MRD Clearance NCT07052695 | Inhye Ahn | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies NCT07107204 | Biotroy Therapeutics | Phase 1 / Phase 2 |
| Recruiting | Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects NCT06800586 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | HEME Home Transfusion Program NCT06487247 | Dana-Farber Cancer Institute | N/A |
| Not Yet Recruiting | The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR NCT07020260 | Princess Maxima Center for Pediatric Oncology | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Stand NCT07082452 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 |
| Not Yet Recruiting | Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies NCT07131449 | The First Affiliated Hospital of Xinxiang Medical College | — |
| Not Yet Recruiting | γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant NCT07123662 | Guangzhou Bio-gene Technology Co., Ltd | EARLY_Phase 1 |
| Not Yet Recruiting | Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia NCT07120607 | Anhui Provincial Hospital | Phase 1 |
| Recruiting | Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic NCT07105579 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Recruiting | Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia NCT07258043 | Hospital General de Mexico | — |
| Recruiting | Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in NCT06824168 | Daiichi Sankyo | Phase 2 |
| Recruiting | A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties NCT07052916 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Mali NCT05237986 | National Cancer Institute (NCI) | — |
| Recruiting | A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia NCT06810583 | St. Jude Children's Research Hospital | Phase 1 |
| Recruiting | Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) NCT07202078 | Monash University | Phase 2 / Phase 3 |
| Recruiting | Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension NCT07202091 | Monash University | Phase 2 / Phase 3 |
| Recruiting | Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) NCT07202052 | Monash University | Phase 2 / Phase 3 |
| Recruiting | Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy NCT06895538 | Peking University First Hospital | — |
| Recruiting | Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) NCT07202065 | Monash University | Phase 2 / Phase 3 |
| Recruiting | Mosaic Trial for Stem Cell Transplant Recipients NCT06960993 | Northwestern University | N/A |
| Recruiting | A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malign NCT07347171 | Cullgen (Shanghai),Inc | Phase 1 |
| Recruiting | Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Inten NCT06409767 | University Hospital, Angers | N/A |
| Recruiting | Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989 | Semmelweis University | — |
| Recruiting | Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing NCT06907797 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HS NCT06839456 | Children's Hospital of Philadelphia | Phase 1 / Phase 2 |
| Recruiting | Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) NCT06644183 | Jennifer R. Brown, MD, PhD | Phase 1 / Phase 2 |
| Active Not Recruiting | Pilot of a Trial Enrollment Diversity Dashboard NCT06795139 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care NCT05745285 | University of Miami | N/A |
| Terminated | YASU Research Registry: For Young Adults With Cancer NCT06275854 | Young Adult Survivors United | — |
| Recruiting | The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease NCT06795815 | Azienda USL Reggio Emilia - IRCCS | N/A |
| Withdrawn | Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells NCT07071909 | UNC Lineberger Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia NCT06890494 | Beijing GoBroad Hospital | EARLY_Phase 1 |
| Recruiting | Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) NCT06469307 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Revumenib in Combination With 7+3 + Midostaurin in AML NCT06313437 | Richard Stone, MD | Phase 1 |
| Recruiting | Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Maligna NCT07270263 | Medical University of Gdansk | N/A |
| Recruiting | Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML NCT06578247 | Daiichi Sankyo | Phase 3 |
| Not Yet Recruiting | Jacobson's Progressive Muscle Relaxation Technique on Children With Leukemia Undergoing Chemotherapy. NCT06631196 | Alexandria University | N/A |
| Not Yet Recruiting | Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia NCT06684509 | Assiut University | Phase 1 / Phase 2 |
| Recruiting | Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Bla NCT06643962 | Affiliated Hospital of Nantong University | N/A |
| Withdrawn | Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease NCT06522373 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | Comparison of Intralipid With SMOF Lipid Following HSCT NCT06625372 | Shahid Beheshti University | N/A |
| Recruiting | Breath Analysis for the Detection of Invasive Fungal Infections NCT06537726 | University of Zurich | — |
| Recruiting | Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia NCT06429449 | University of Colorado, Denver | Phase 1 |
| Recruiting | PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) NCT06430736 | Insel Gruppe AG, University Hospital Bern | Phase 2 |
| Recruiting | DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics NCT06296368 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrom NCT06501196 | BlossomHill Therapeutics | Phase 1 |
| Recruiting | A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes NCT06229912 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients NCT06704243 | University Health Network, Toronto | N/A |
| Active Not Recruiting | Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors NCT06053268 | St. Jude Children's Research Hospital | N/A |
| Recruiting | Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies NCT06408194 | Stanford University | Phase 1 |
| Not Yet Recruiting | BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children NCT06347458 | Guangzhou Bio-gene Technology Co., Ltd | Phase 1 |
| Completed | False Positive Peripheral Blood Culture in Children With Leukaemia: A Prevalence Study NCT06336837 | Ege University | — |
| Not Yet Recruiting | RAT-HEMATO : Return to Work After Malignant Hemopathy NCT06262789 | University Hospital, Angers | N/A |
| Recruiting | I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients NCT05842603 | Massachusetts General Hospital | N/A |
| Active Not Recruiting | Integrated Actionable Aging Assessment for Cancer Patients Pilot NCT05871008 | University of Colorado, Denver | N/A |
| Recruiting | Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT06001788 | Kura Oncology, Inc. | Phase 1 |
| Recruiting | CIML NK Cells With Venetoclax for AML NCT06152809 | Dana-Farber Cancer Institute | Phase 1 |
| Recruiting | Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on NCT06360718 | Children's Hospital Los Angeles | N/A |
| Recruiting | Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation NCT06138587 | Dana-Farber Cancer Institute | Phase 1 |
| Active Not Recruiting | Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematolog NCT06026046 | University Hospital, Angers | N/A |
| Recruiting | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801 | Children's Hospital Medical Center, Cincinnati | — |
| Unknown | Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT NCT06177561 | Ruijin Hospital | N/A |
| Terminated | A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokine NCT06021600 | M.D. Anderson Cancer Center | Phase 1 |
| Unknown | 90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia NCT04856215 | Great Ormond Street Hospital for Children NHS Foundation Trust | Phase 2 |
| Completed | Insomnia Prevention in Children With Acute Lymphoblastic Leukemia NCT05866887 | Dana-Farber Cancer Institute | N/A |
| Recruiting | High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) NCT07205523 | Yigeng Cao,MD,PhD | — |
| Withdrawn | H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis NCT00488605 | University of New Mexico | Phase 3 |
| Recruiting | Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for NCT05645718 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia NCT05886491 | Takeda | Phase 1 / Phase 2 |
| Recruiting | Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia NCT06353698 | National Nutrition and Food Technology Institute | N/A |
| Unknown | Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) NCT05692713 | University of British Columbia | — |
| Recruiting | Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia NCT05793801 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Unknown | Musculoskeletal Health in Adult Haematological Cancer Survivors NCT05865678 | The Christie NHS Foundation Trust | — |
| Recruiting | MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing NCT05794880 | Medical College of Wisconsin | N/A |
| Withdrawn | Donor Enriched Activated NK Cell Infusion Post Haploidentical Stem Cell Transplant for Refractory Myeloid Mali NCT05375253 | University of Nebraska | Phase 1 |
| Terminated | Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patient NCT05464836 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Oncology Care at Home for BMT and CAR-T NCT05826288 | University of Colorado, Denver | N/A |
| Completed | Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunot NCT05763563 | H. Lee Moffitt Cancer Center and Research Institute | N/A |
| Unknown | Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia NCT04100187 | Kecellitics Biotech Company Ltd | Phase 1 |
| Unknown | Multiphasic Prehab Allo-HSCT NCT05649371 | University of Calgary | N/A |
| Withdrawn | Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy NCT05362331 | University of California, San Francisco | N/A |
| Recruiting | Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular T NCT05646576 | Massachusetts General Hospital | N/A |
| Recruiting | Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome NCT05673057 | Molecular Partners AG | Phase 1 / Phase 2 |
| Terminated | ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals NCT05655546 | Scripps Translational Science Institute | N/A |
| Recruiting | Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-na NCT05536349 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Improving Patient Experience: BMBA NCT05690230 | Thomas Jefferson University | N/A |
| Active Not Recruiting | Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocyt NCT05479994 | BeiGene | Phase 2 |
| Completed | Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Can NCT04593277 | Fred Hutchinson Cancer Center | N/A |
| Recruiting | MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 NCT05691608 | Gustave Roussy, Cancer Campus, Grand Paris | N/A |
| Completed | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors NCT05131815 | Cedars-Sinai Medical Center | N/A |
| Unknown | Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractor NCT05480501 | Beijing Immunochina Medical Science & Technology Co., Ltd. | EARLY_Phase 1 |
| Recruiting | European Rare Blood Disorders Platform (ENROL) NCT06250595 | Hospital Universitari Vall d'Hebron Research Institute | — |
| Completed | CD155 Expression in Acute Myeloid Leukemia NCT06369662 | Assiut University | — |
| Recruiting | Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) NCT05403177 | University Health Network, Toronto | — |
| Active Not Recruiting | A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients W NCT05268003 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881 | Adela, Inc | — |
| Recruiting | Early Integration of Palliative and Supportive Care in Cellular Therapy NCT05190653 | Alberta Health Services, Calgary | N/A |
| Unknown | Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractor NCT05309213 | Beijing Immunochina Medical Science & Technology Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families NCT05425992 | University of Colorado, Denver | — |
| Completed | Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy NCT05064787 | Pack Health | N/A |
| Recruiting | Investigating Cognitive Impairment in Young Patients With Cancer Prospectively NCT05840575 | Rigshospitalet, Denmark | — |
| Withdrawn | Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leuk NCT04961801 | Shin Mineishi | Phase 1 / Phase 2 |
| Recruiting | Early Ageing During Therapy in AYA Cancer Patients NCT05062707 | University Medical Center Groningen | — |
| Recruiting | Solving Riddles Through Sequencing NCT05046444 | Munich Leukemia Laboratory | — |
| Completed | Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation NCT05282459 | Tian Yi Zhang | Phase 1 / Phase 2 |
| Completed | Peppermint Inhalation Versus Swedish Massage on Chemotherapy Induced-Nausea and Vomiting in Children With Leuk NCT06095726 | Alexandria University | N/A |
| Active Not Recruiting | Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy fo NCT04541212 | Montreal Heart Institute | — |
| Withdrawn | SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies NCT05393999 | Imperial College Healthcare NHS Trust | Phase 2 |
| Unknown | Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignanc NCT05203809 | Malaghan Institute of Medical Research | — |
| Recruiting | Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant NCT04898790 | University of Nebraska | N/A |
| Completed | Technology-Assisted Yoga and Exercise on Neuropathy and Pain in Children With Leukemia NCT06512012 | Dokuz Eylul University | N/A |
| Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266 | Sanguine Biosciences | — |
| Suspended | A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) NCT05168904 | Cyclacel Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Completed | A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib NCT05743465 | Takeda | — |
| Active Not Recruiting | SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer NCT04977024 | GeoVax, Inc. | Phase 2 |
| Completed | Providing Web-based Training to Parents Of Children With Leukemia NCT06357585 | Saglik Bilimleri Universitesi | N/A |
| Recruiting | Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies NCT05528887 | The Affiliated People's Hospital of Ningbo University | Phase 1 |
| Unknown | A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy o NCT05061147 | Maxinovel Pty., Ltd. | Phase 1 / Phase 2 |
| Completed | Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events NCT05123001 | Stanford University | — |
| Completed | Removing Transfusion Dependence as a Barrier to Hospice Enrollment NCT05063591 | Adam Olszewski | N/A |
| Withdrawn | A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 NCT04556266 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Terminated | First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML NCT04840784 | Shengke Pharmaceuticals Pty Ltd | Phase 1 |
| Completed | IIT2020-20-SHIRAZIP-WALK: Nature Walks NCT04896580 | Cedars-Sinai Medical Center | N/A |
| Recruiting | Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens Fro NCT04968834 | Dana-Farber Cancer Institute | — |
| Completed | Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell NCT05784415 | AIDS Malignancy Consortium | — |
| Completed | The Effect of Mucositis Care Training Given to Caregivers in Pediatric Leukemia Cases on Mucosal Barrier Damag NCT04813783 | Ege University | — |
| Completed | A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic NCT04847050 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL NCT03271515 | Beijing Doing Biomedical Co., Ltd. | Phase 1 |
| Unknown | Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL NCT02546739 | Beijing Doing Biomedical Co., Ltd. | Phase 1 |
| Completed | Patient Reported Outcomes and Patient Education in Cellular Therapy Patients NCT04853277 | Dartmouth-Hitchcock Medical Center | N/A |
| Active Not Recruiting | Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer NCT04706676 | Rigshospitalet, Denmark | N/A |
| Unknown | Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance NCT04965649 | Centre Hospitalier Universitaire de Nīmes | — |
| Unknown | A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT. NCT04688021 | Yi Luo | Phase 2 |
| Completed | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients NCT04604158 | Gillian Gresham | N/A |
| Recruiting | National Longitudinal Cohort of Hematological Diseases NCT04645199 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Unknown | Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study NCT04372524 | University of British Columbia | — |
| Completed | Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivo NCT04472286 | University of Nebraska | — |
| Active Not Recruiting | Tempus Priority Study: A Pan-tumor Observational Study NCT05179824 | Tempus AI | — |
| Active Not Recruiting | A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractor NCT04571138 | Seattle Children's Hospital | Phase 1 / Phase 2 |
| Completed | Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") NCT04474678 | Medical University of Vienna | N/A |
| Active Not Recruiting | A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree NCT04547049 | First Affiliated Hospital of Zhejiang University | Phase 3 |
| Unknown | Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Disea NCT04504526 | First Affiliated Hospital of Fujian Medical University | EARLY_Phase 1 |
| Unknown | Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Maligna NCT04497701 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | N/A |
| Unknown | hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation NCT03759899 | Peking University People's Hospital | — |
| Unknown | Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors i NCT04610125 | Hebei Senlang Biotechnology Inc., Ltd. | N/A |
| Completed | CAR-37 T Cells in Hematologic Malignancies NCT04136275 | Marcela V. Maus, M.D.,Ph.D. | Phase 1 |
| Unknown | Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treat NCT04406285 | Federal University of Health Science of Porto Alegre | N/A |
| Terminated | Natural Killer Cell (CYNK-001) Infusions in Adults with AML NCT04310592 | Celularity Incorporated | Phase 1 |
| Unknown | Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation NCT04496011 | Federal University of Health Science of Porto Alegre | N/A |
| Unknown | Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL NCT04163575 | Kecellitics Biotech Company Ltd | Phase 1 / Phase 2 |
| Completed | Early Diagnosis of Leukemic Children Patients Based on Clinical, Age Estimation and Radiographical Evaluation NCT04756258 | Tanta University | — |
| Recruiting | Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or So NCT03934372 | Incyte Biosciences International Sàrl | Phase 1 / Phase 2 |
| Completed | A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukem NCT03873493 | AbbVie | Phase 2 |
| Recruiting | Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies NCT05011045 | M.D. Anderson Cancer Center | — |
| Recruiting | Better Leukemia Diagnostics Through AI (BELUGA) NCT04466059 | Munich Leukemia Laboratory | — |
| Completed | Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas NCT04101123 | Martin-Luther-Universität Halle-Wittenberg | — |
| Terminated | Physical Activity Adapted at Home Supervised by Videoconferencing in Post-cancer for Children / AYA Treated fo NCT04136665 | University Hospital, Montpellier | N/A |
| Recruiting | A Study in Leukemia Patients With Karonudib NCT04077307 | Thomas Helleday Foundation | Phase 1 |
| Unknown | Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma NCT04271800 | Chongqing Precision Biotech Co., Ltd | Phase 1 / Phase 2 |
| Unknown | Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia NCT04272125 | Chongqing Precision Biotech Co., Ltd | Phase 1 / Phase 2 |
| Unknown | Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation NCT03836690 | University College, London | Phase 1 |
| Recruiting | Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemi NCT06155188 | Nanfang Hospital, Southern Medical University | N/A |
| Completed | Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu NCT04092803 | University of Colorado, Denver | N/A |
| Terminated | RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation NCT03948529 | University Hospital, Lille | Phase 2 |
| Unknown | CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia NCT04265963 | Chongqing Precision Biotech Co., Ltd | Phase 1 / Phase 2 |
| Active Not Recruiting | Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion NCT03722407 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Active Not Recruiting | AZD6738 for Patients With Progressive MDS or CMML NCT03770429 | Massachusetts General Hospital | Phase 1 |
| Active Not Recruiting | Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts NCT03974217 | Dana-Farber Cancer Institute | Phase 1 |
| Unknown | Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia NCT04037189 | Rabin Medical Center | — |
| Completed | Cardiovascular Effects of CART Cell Therapy NCT04026737 | Abramson Cancer Center at Penn Medicine | — |
| Terminated | Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia NCT03759184 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eli NCT03677596 | Pfizer | Phase 4 |
| Unknown | ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma NCT04014894 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 |
| Unknown | CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma NCT04271410 | Chongqing Precision Biotech Co., Ltd | Phase 1 / Phase 2 |
| Terminated | HeartPhone Cancer Survivors Trial 2019 NCT03953326 | Penn State University | Phase 1 / Phase 2 |
| Unknown | Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy NCT03910842 | Timmune Biotech Inc. | EARLY_Phase 1 |
| Terminated | PROactive Evaluation of Function to Avoid CardioToxicity NCT03862131 | Washington University School of Medicine | Phase 2 |
| Terminated | Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL NCT03708003 | Swiss Cancer Institute | Phase 2 |
| Unknown | Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance NCT04074213 | University Hospital, Caen | — |
| Completed | Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever NCT04187755 | Indonesia University | Phase 4 |
| Completed | Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With Hi NCT03538587 | National Cancer Institute (NCI) | N/A |
| Completed | Immunophenotyping of Blast Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples F NCT03801005 | Assistance Publique Hopitaux De Marseille | — |
| Unknown | Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation NCT04336501 | Beijing Immunochina Medical Science & Technology Co., Ltd. | N/A |
| Active Not Recruiting | A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lym NCT03793140 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia NCT03826992 | Children's Hospital Medical Center, Cincinnati | Phase 1 |
| Active Not Recruiting | CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma NCT03684889 | Seattle Children's Hospital | Phase 1 |
| Unknown | Efficacy of FLAG Regimen for the Treatment of Patients With AML NCT03600558 | Tianjin Medical University General Hospital | — |
| Completed | Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer NCT03654716 | Dana-Farber Cancer Institute | Phase 1 |
| Completed | Resiliency in Older Adults Undergoing Bone Marrow Transplant NCT04188678 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Unknown | A Study on the Uterus, Ovarian and Reproductive Functions According to Conditioning Regimen and Pubertal Statu NCT03583294 | Assistance Publique Hopitaux De Marseille | N/A |
| Active Not Recruiting | Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell T NCT03057054 | Children's Oncology Group | Phase 3 |
| Active Not Recruiting | Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) NCT03496402 | Institut Curie | N/A |
| Terminated | A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies NCT03404726 | Bayer | Phase 1 |
| Completed | Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation NCT03342196 | Case Comprehensive Cancer Center | Phase 2 |
| Unknown | Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies NCT03624686 | National Taiwan University Hospital | — |
| Completed | Respiratory Training in Patients With Leukemia NCT03876834 | Cairo University | N/A |
| Recruiting | HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After NCT03326921 | Fred Hutchinson Cancer Center | Phase 1 |
| Unknown | Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology NCT06335277 | European Institute of Oncology | — |
| Active Not Recruiting | A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated C NCT03410875 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation NCT03434730 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Exercise as an Immune Adjuvant for Allogeneic Cell Therapies NCT06643221 | University of Arizona | EARLY_Phase 1 |
| Recruiting | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774 | Massive Bio, Inc. | — |
| Unknown | Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transpl NCT03373526 | Daniel Godoy Martinez | N/A |
| Completed | Socio-psychological Factors Involved in the Hematopoietic Stem Cell Transplantation Process in People With Hem NCT03883672 | Saint-Louis Hospital, Paris, France | N/A |
| Active Not Recruiting | A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leuke NCT03330691 | Seattle Children's Hospital | Phase 1 |
| Unknown | WB-EMS and Nutrition in Patients With Hematological Malignancies NCT03556748 | University of Erlangen-Nürnberg Medical School | N/A |
| Recruiting | Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL NCT03319901 | Dana-Farber Cancer Institute | Phase 1 / Phase 2 |
| Unknown | Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL NCT02656147 | Beijing Doing Biomedical Co., Ltd. | Phase 1 |
| Unknown | CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies NCT03312205 | Hebei Senlang Biotechnology Inc., Ltd. | Phase 1 / Phase 2 |
| Completed | A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hemato NCT03126045 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Unknown | Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies NCT03262298 | Affiliated Hospital to Academy of Military Medical Sciences | Phase 1 / Phase 2 |
| Terminated | Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BM NCT03016130 | University of Florida | Phase 3 |
| Terminated | Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia NCT02730884 | M.D. Anderson Cancer Center | Phase 2 |
| Enrolling By Invitation | Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing NCT03226704 | National Cancer Institute (NCI) | — |
| Recruiting | Liquid Biopsy Evaluation and Repository Development at Princess Margaret NCT03702309 | University Health Network, Toronto | — |
| Active Not Recruiting | A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma NCT03244306 | Seattle Children's Hospital | Phase 1 |
| Withdrawn | Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study NCT03086252 | Emory University | N/A |
| Completed | Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemot NCT03399331 | American University of Beirut Medical Center | Phase 1 |
| Completed | Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS NCT03066648 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therap NCT03144583 | Sara V. Latorre | Phase 1 |
| Completed | Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T) NCT03173417 | Beijing Immunochina Medical Science & Technology Co., Ltd. | Phase 1 / Phase 2 |
| Terminated | Effect of Prevention Education in Caries Formation in Pediatric Patients With Leukemia NCT03281746 | Virginia Commonwealth University | N/A |
| Unknown | Laboratory Studies Into the Pathology of Leukaemia NCT03233763 | Royal Marsden NHS Foundation Trust | — |
| Unknown | TKI Discontinuation in CML Patients of China NCT03251352 | Shenzhen Second People's Hospital | — |
| Completed | Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors NCT03052777 | University of Alberta | N/A |
| Recruiting | Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes NCT03058588 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | — |
| Unknown | CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies NCT03121625 | Hebei Senlang Biotechnology Inc., Ltd. | Phase 1 |
| Terminated | Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF- NCT02773732 | University of Florida | Phase 1 / Phase 2 |
| Terminated | The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Q NCT02976558 | University of Erlangen-Nürnberg Medical School | N/A |
| Unknown | Pre-existing Kinase Domain Mutations in Ph-positive Leukemias NCT02643888 | St. Anna Kinderkrebsforschung | — |
| Completed | Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on NCT02948413 | National Institutes of Health Clinical Center (CC) | — |
| Unknown | A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies NCT02954445 | Southwest Hospital, China | Phase 1 / Phase 2 |
| Completed | CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT NCT02942173 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 2 / Phase 3 |
| Active Not Recruiting | Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not R NCT02932280 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Terminated | Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Le NCT02709083 | Emory University | Phase 2 |
| Unknown | A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies NCT02958410 | Southwest Hospital, China | Phase 1 / Phase 2 |
| Unknown | A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies NCT02935153 | Southwest Hospital, China | Phase 1 / Phase 2 |
| Unknown | A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies NCT02937103 | Southwest Hospital, China | Phase 1 / Phase 2 |
| Completed | A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia NCT02723994 | Incyte Corporation | Phase 2 |
| Completed | Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lym NCT02910583 | Pharmacyclics LLC. | Phase 2 |
| Completed | Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVH NCT02663622 | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Suspended | CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation NCT02910752 | Shanghai Jiao Tong University School of Medicine | Phase 1 / Phase 2 |
| Completed | Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FL NCT02668653 | Daiichi Sankyo | Phase 3 |
| Withdrawn | Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patien NCT02829840 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Unknown | Safety and Efficacy Evaluation of IM19 CAR-T Cells NCT03142646 | Beijing Immunochina Medical Science & Technology Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome NCT02859389 | St. Jude Children's Research Hospital | — |
| Active Not Recruiting | Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant NCT02477878 | Bellicum Pharmaceuticals | Phase 1 |
| Unknown | Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation NCT02784561 | Chinese PLA General Hospital | Phase 4 |
| Completed | Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies NCT02795182 | BeiGene | Phase 1 |
| Unknown | Evaluation of the Effectiveness of an Aldehyde Inhibitor Dehydrogenases (DIMATE) on the Cell Population Leukem NCT02748850 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy NCT02796365 | Henry Ford Health System | N/A |
| Completed | LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT02652871 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents NCT02763475 | Instituto de Investigación Hospital Universitario La Paz | Phase 2 |
| Withdrawn | Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT NCT02786485 | Bellicum Pharmaceuticals | Phase 1 |
| Completed | Early Life Exposures in Agriculture NCT02743481 | National Cancer Institute (NCI) | — |
| Terminated | Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) NCT02599649 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies NCT02710149 | Southwest Hospital, China | Phase 1 / Phase 2 |
| Completed | Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation NCT02719821 | University of Wisconsin, Madison | N/A |
| Unknown | Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL NCT03564470 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL NCT03564704 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Terminated | Medical Treatment Decision Making Using Adaptive Conjoint Analysis NCT02608307 | St. Jude Children's Research Hospital | — |
| Completed | iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy NCT02564484 | St. Jude Children's Research Hospital | — |
| Completed | Post-transfusion Platelet Count NCT02601131 | Region Skane | — |
| Completed | Aberrant Myeloid Lineage Differentiation in HIV/AIDS Patients NCT05808803 | Zhongnan Hospital | — |
| Completed | Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Mye NCT02530476 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Unknown | Interferon-α After DLI for the Prevention of Relapse NCT02568241 | Peking University People's Hospital | Phase 1 / Phase 2 |
| Completed | Illness Management and Parental Adjustment to Cancer Treatment NCT02505165 | Children's Hospital Medical Center, Cincinnati | N/A |
| Terminated | Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia NCT02419469 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis NCT02593123 | Virginia Commonwealth University | Phase 2 |
| Completed | Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplanta NCT02598752 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemi NCT02735291 | Sinobioway Cell Therapy Co., Ltd. | N/A |
| Completed | Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy NCT02638467 | University of Milano Bicocca | Phase 2 |
| Unknown | Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL NCT02799550 | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Phase 1 |
| Withdrawn | Randomized Trial of Mobilized Blood/Marrow Versus Blood Transplant NCT01617473 | Peking University People's Hospital | N/A |
| Terminated | Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) NCT02469415 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients NCT02385110 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acu NCT02441803 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome NCT02530463 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers NCT02409121 | University of Michigan Rogel Cancer Center | N/A |
| Completed | Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors NCT02192333 | Fred Hutchinson Cancer Center | N/A |